Developing breakthrough therapies involves significant time, money, and uncertainty, and requires strong evidence-generation to prove value. Real-world data (RWD) from EHRs can help pharmaceutical and medical device companies inform development strategy and alleviate some of these pressures as they seek to bring products to market and prove their efficacy.  

• How clinical expert-led AI is being used to normalize massive streams of daily EHR data for research
• What differentiates RWD sources and what to look for when considering data sources for pre- and post-market studies
• Ways RWD can be used to inform decisions made throughout the product development process, using real-life examples from Reprieve Cardiovascular